Retinal Vein Occlusion  >>  triamcinolone acetonide + anti-VEGF (CLS-1003)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
triamcinolone acetonide + anti-VEGF (CLS-1003) / Clearside Biomedical
TANZANITE, NCT02303184: Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

Completed
2
46
US
4 mg CLS-TA, Sham, suprachoroidal sham, IVT aflibercept, Eylea
Clearside Biomedical, Inc.
Macular Edema, Retinal Vein Occlusion
03/16
03/16

Download Options